Catalytic properties of polymorphic human cytochrome P450 1B1 variants

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1607-1613

  Shimada, Tsutomu ^a   Watanabe, Junko ^b   Kawajiri, Kaname ^b   Sutter, Thomas R ^c   Guengerich, F Peter ^d   Gillam, Elizabeth M J ^e   Inoue, Kiyoshi ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ESTRADIOL; ESTRONE; PROGESTERONE; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; TESTOSTERONE;

ARTICLE; BACTERIAL MEMBRANE; CATALYSIS; CHEMICAL REACTION KINETICS; ENZYME POLYMORPHISM; ESCHERICHIA COLI; GENE MUTATION; HUMAN; HYDROXYLATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ALLELES; ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; HUMANS; HYDROXYLATION; PROGESTERONE; STEROID 16-ALPHA-HYDROXYLASE; TESTOSTERONE;

EID: 0032867995     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1607     Document Type: Article

References (38)

1. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. and Watanabe, J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett., 263, 131-133.
2. Nakachi, K., Imai, K., Hayashi, S. and Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.
3. Kawajiri, K. and Fujii-Kuriyama, Y. (1991) P450 and human cancer. Jpn J. Cancer Res., 82, 1325-1335.
4. 462 assessment of a role for the rare allele in carcinogenesis. Cancer Res., 56, 3926-3933.
5. Persson, I., Johansson, I. and Ingelman-Sundberg, M. (1997) In vitro kinetics of two human CYP1A1 variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. Biophys. Res. Commun., 231, 227-230.
6. Shimada, T., Hayes, C.L., Yamazaki, H., Amin, S., Hecht, S.S., Guengerich, F.P. and Sutter, T.R. (1996) Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res., 56, 2979-2984,
7. Larsen, M.C., Angus, W.G.R., Brake, P.B., Eltom, S.E., Sukow, K.A. and Jefcoate, C.R. (1998) Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Res., 58, 2366-2374.
8. Eltom, S.E., Larsen, M.C. and Jefcoate, C.R. (1998) Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis, 19, 1437-1444.
9. Huang, Z., Fasco, M.J., Figge, H.L., Keyomars, F.K. and Kaminsky, L.S. (1996) Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos., 24, 899-905.
10. Spink, D.C., Spink, B.C., Cao, J.Q., Gierthy, J.F., Hayes, C.L., Li, Y. and Sutter, T.R. (1997) Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. J. Steroid Biochem. Mol. Biol., 62, 223-232.
11. Liehr, J.G. and Rocci, M.J. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl Acad. Sci. USA, 93, 3294-3296.
12. Spink, D.C., Eugster, H.P., Lincoln, D.W., Schuetz, J.D., Schuetz, E.G., Johnson, J.A., Kaminsky, L.S. and Gierthy, J.F. (1992) 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys., 293, 342-348.
13. Yamazaki, H., Shaw, P.M., Guengerich, F.P. and Shimada, T. (1998) Roles of cytochrome P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem. Res. Toxicol., 11, 659-665.
14. Stoilov, I., Akarsu, A.N., Alozie, I. et al. (1998) Sequence analysis and homology modeling suggest that primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P4501B1. Am. J. Hum. Genet., 62, 573-584.
15. Bailey, L.R., Roodi, N., Dupont, W.D. and Parl, F.F. (1998) Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res., 58, 5038-5041.
16. Bejjani, B.A., Lewis, R.A., Tomey, K.F., Anderson, K.L., Dueker, D.K., Jabak, M., Astle, W.F., Otterud, B., Leppert, M. and Lupski, J.R. (1998) Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am. J. Hum. Genet., 62, 325-333.
17. Shimada, T., Wunsch, R.M., Hanna, I.H., Sutter, T.R., Guengerich, F.P. and Gillam, E.M.J. (1998) Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch. Biochem. Biophys., 357, 111-120.
18. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F.P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414-423.
19. Yamazaki, H., Inoue, K., Turvy, C.G., Guengerich, F.P. and Shimada, T. (1997) Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metab. Dispos., 25, 168-174.
20. Parikh, A., Gillam, E.M.J. and Guengerich, F.P. (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nature Biotechnol., 15, 784-788.
21. Yamazaki, H. and Shimada, T. (1997) Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch. Biochem. Biophys., 346, 161-169.
22. Shimada, T., Iwasaki, M., Martin, M.V. and Guengerich, F.P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res., 49, 3218-3228.
23. Shimada, T., Oda, Y., Yamazaki, H., Mimura, M. and Guengerich, F.P. (1994) SOS function tests for studies of chemical carcinogenesis using Salmonella typhimurium TA1535/pSK1002, NM2009, and NM3009. In Adolph, K.W. (ed.) Methods in Molecular Genetics, Vol. 5, Gene and Chromosome Analysis, Part C. Academic Press, San Diego, CA, pp. 342-355.
24. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378.
25. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
26. Meyer, U.A., Gut, J., Kronbach, T., Skoda, C., Meier, U.T. and Catin, T. (1986) The molecular mechanisms of two common polymorphisms of drug oxidation - evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica, 16, 449-464.
27. Saner, H., Gurtner, H.P., Preisig, R. and Kupfer, A. (1986) Polymorphic debrisoquine and mephenytoin hydroxylation in patients with pulmonary hypertension of vascular origin after aminorex fumarate. Eur. J. Clin. Pharmacol., 31, 437-442.
28. Daniel, H.I. and Edeki, T.I. (1996) Genetic polymorphism of S-mephenytoin 4'-hydroxylation. Psychopharmacol. Bull., 32, 219-230.
29. Meyer, U.A. (1990) Molecular genetics and the future of pharmacogenetics. Pharmacol. Ther., 46, 349-355.
30. Kalow, W. (1987) Genetic variation in the human hepatic cytochrome P-450 system. Eur. J. Clin. Pharmacol., 31, 633-641.
31. Smith, C.A.D., Smith, G. and Wolf, C.R. (1995) Genetic polymorphisms in xenobiotic metabolism. Eur. J. Cancer, 30, 1921-1935.
32. Hayashi, S.I., Watanabe, J., Nakachi, K. and Kawajiri, K. (1991) Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem. (Tokyo), 110, 407-411.
33. Yager, J.D. and Liehr, J.G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36, 203-232.
34. Crespi, C.L. and Penman, B.W. (1997) Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions. Adv. Pharmacol., 43, 171-188.
35. Guengerich, F.P., Parikh, A., Johanson, E.F. et al. (1997) Heterologous expression of human drug-metabolizing enzymes. Drug Metab. Dispos., 25, 1234-1241.
36. Yamazaki, H., Inoue, K., Shaw, P.M., Checovich, W.J., Guengerich, F.P. and Shimada, T. (1997) Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. J. Pharmacol. Exp. Ther., 283, 434-442.
37. Ralston, S.L., Seidel, A., Luch, A., Platt, K.L. and Baird, W.M. (1995) Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti(11R,12S, 135, 14R)-and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,13-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis, 16, 2899-2907.
38. Spink, D.C., Spink, B.C., Cao, J.Q., De Pasquale, J.A., Pentecost, B.T., Fasco, M.J., Li, Y. and Sutter, T.R. (1998) Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis, 19, 291-298.